We represent you in Japan.
APITAS — Active Pharmaceutical Ingredient Talent As a Service.

Japan Business Development Partner
for Pharma & API Companies.

For Overseas Manufacturers

Does this sound familiar?

✕Hard to reach the right people at Japanese pharma companies
✕Language and cultural barriers slow down every decision
✕No local presence means no trust — and no meetings
✕Regulatory requirements are unclear without a Japan expert
✕Hiring a full-time Japan representative is too costly to justify
✕Distributors don't represent you — they represent themselves

That's exactly why T&N Partners exists.

We remove every one of these barriers — acting as your dedicated Japan team, without the overhead of a local entity.

Why Choose Us

Why T&N Partners

Four reasons overseas manufacturers choose us as their Japan partner.

01

Deep Industry Roots

Our background spans pharmaceutical APIs, specialty chemicals, and CDMO business development — built through years of direct execution at leading Japanese and global companies.

02

A Network You Can't Build Overnight

Direct, working relationships with Japanese pharmaceutical manufacturers, CDMOs, trading companies, and industry decision-makers. We open doors that take years to reach on your own.

03

Execution, Not Just Advice

We don't hand you a report and step back. We attend meetings, manage timelines, negotiate terms, and handle communication — and stay until the deal is done.

04

Bilingual. Bicultural. Business-Fluent.

Seamless communication between your team and Japanese partners — in English and Japanese, with the cultural fluency that prevents the misunderstandings that kill deals.

What We Do

Our Services

Practical support across the full cycle of Japan market entry — from first assessment to commercial launch.

01
Japan Communication Agent
Your dedicated representative in Japan.
We represent you directly with Japanese pharmaceutical companies, CDMOs, distributors, and trading companies — handling outreach, meetings, negotiations, follow-ups, and project coordination entirely on your behalf.
Ideal for: Overseas manufacturers without a Japan entity or local sales team.
02
Market Intelligence
Know your market before you move.
In-depth analysis of market size, growth trends, regulatory landscape, competitor positioning, and pricing dynamics. We provide the intelligence you need to build a credible Japan entry strategy.
Ideal for: Companies evaluating Japan market potential before committing resources.
03
Regulatory & Compliance Support
Navigate Japan's regulatory environment with confidence.
End-to-end support through PMDA requirements, import application processes for investigational APIs, quality audit coordination, and ongoing compliance communication.
Ideal for: API and CDMO companies at clinical or commercial stage requiring Japan import approval.
04
CDMO & Distributor Matching
The right partner, faster.
Identification and introduction of suitable Japanese manufacturing partners, CDMOs, and distribution channels based on your technical requirements and commercial goals.
Ideal for: Overseas companies seeking manufacturing or commercial partnerships in Japan.
05
Trade Show & Business Development
On-the-ground execution at Japanese exhibitions.
Full support at Japanese pharmaceutical and chemical trade shows — from booth setup, visitor engagement, and interpretation to post-show follow-up and deal progression.
Ideal for: Companies exhibiting at CPhI Japan, Interphex Japan, or targeting specific Japanese buyers.

Industries & Product Categories We Cover

APIsExcipientsFinished FormulationsCDMO / CMOMedical DevicesSpecialty ChemicalsNutraceuticalsOTC ProductsBiotech / BiologicsFood IngredientsCosmetic Ingredients
Track Record

Case Studies

A selection of engagements. Client names withheld under NDA.

CASE STUDY 01
Japan Market Entry for an Overseas API Manufacturer
Pharmaceutical API · Overseas Manufacturer
Challenge
An overseas API manufacturer with no Japan presence sought Japanese pharmaceutical customers. Language, regulatory complexity, and lack of local contacts were significant barriers.
What We Did
  • Conducted targeted customer mapping across Japanese pharma companies
  • Secured introductory meetings with qualified prospects
  • Managed all Japanese-language communication on the client's behalf
  • Coordinated regulatory documentation for the Japan import application
Result
Multiple commercial discussions established. First-contact-to-meeting conversion with partners previously inaccessible without local representation.
CASE STUDY 02
CDMO Partner Search & Technical Introduction
Drug Formulation · Development-Stage Company
Challenge
A development-stage company required a Japanese CDMO with specific technical capabilities. Cold outreach yielded no responses; the client lacked local credibility.
What We Did
  • Shortlisted Japanese CDMOs matching technical and commercial requirements
  • Facilitated warm introductions via existing relationships
  • Coordinated technical agendas and acted as bilingual intermediary
  • Supported follow-up and proposal evaluation
Result
Two qualified CDMO introductions. One progressed to feasibility study stage. Time to first technical meeting: under 6 weeks.